Results 91 to 100 of about 29,753 (220)

Fatal pulmonary embolism following shoulder arthroplasty: a case report [PDF]

open access: yes, 2009
Introduction Fatal pulmonary embolism following a shoulder joint replacement is a rare event. The exact prevalence of shoulder arthroplasties is not clear.
Thayur R Madhusudhan   +3 more
core   +2 more sources

Computed Tomography Yield and Predictors of Pulmonary Embolism in Mechanically Ventilated Patients—A Retrospective Study

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 4, April 2026.
ABSTRACT Background The reported prevalence of pulmonary embolism (PE) detected during intensive care varies substantially. Computed tomography pulmonary angiography (CTPA) is the diagnostic reference method, but assessing pre‐test probability and finding distinct indications for CTPA from clinical observations is difficult in mechanically ventilated ...
Erik Bruno   +6 more
wiley   +1 more source

Variations in Perioperative Thromboprophylaxis Practices: Do the Guidelines Need a Closer Look?

open access: yesAnnals of Thoracic Surgery Short Reports
Background: In 2022, the American Association for Thoracic Surgery (AATS) and the European Society of Thoracic Surgeons (ESTS) published joint guidelines regarding the timing, duration, and choice of agent for perioperative venous thromboembolism ...
Russell Seth Martins, MD   +6 more
doaj   +1 more source

Update on Extended Treatment for Venous Thromboembolism [PDF]

open access: yes, 2018
The importance of assessing the probability of venous thromboembolism recurrence, a condition that includes deep vein thrombosis and pulmonary embolism, lies in the fact that it is the most important factor in deciding the duration of anticoagulant ...
Del Toro-Cervera, Jorge   +7 more
core   +2 more sources

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 2, Page 259-271, April 2026.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Venous Thromboembolism Risk Assessment Among Ambulatory Cancer Patients: Demographic Study and Doctor's Adherence to Guidelines [PDF]

open access: yesAl-Anbar Medical Journal
Background: Cancer-associated thrombosis (CAT) is the second cause of death for cancer patients. National Comprehensive Cancer Network (NCCN) guidelines recommend assessing CAT risk for all ambulatory cancer patients by Khorana score and prescribing ...
Marwa Tariq, Ehab Mikhael
doaj   +1 more source

A Retrospective Study of Adult and Pediatric D‐Dimer Tests to Identify Opportunities for Improved Utilization

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 2, Page 392-401, April 2026.
ABSTRACT Introduction D‐dimers are produced by lysis of cross‐linked fibrin. In children, D‐dimer testing is used to evaluate disseminated intravascular coagulation (DIC) and some inflammatory states, but its use is not validated for screening or ruling out suspected venous thromboembolic events (VTE).
Rabab Al Dawood   +4 more
wiley   +1 more source

Simple measures can improve care in our hospitals : an audit of venous thromboembolism practice [PDF]

open access: yes, 2013
: Venous thromboembolism (VTE) is a serious but preventable complication of hospitalisation. Doctors still sometimes fail to adhere to them, thus putting patients at risk and incurring considerable expense for the national health service.
Azzopardi, Stephanie   +3 more
core  

Evaluation of venous thromboembolism prophylaxis in a high complexity hospital [PDF]

open access: yes, 2010
OBJECTIVE: This study aimed at assessing the adequacy of thromboprophylaxis in a high complexity hospital in Vitória - ES, analysing the possible predictors of inadequate prescriptions and/or procedures.
Carneiro, João Luiz De Aquino   +2 more
core   +2 more sources

Endothelial Cell‐Specific Molecule‐1 (ESM1): An Endogenous Anticoagulant and Protective Factor in Venous Thrombosis

open access: yesAdvanced Science, Volume 13, Issue 16, 18 March 2026.
This study identifies ESM1 as an endogenous anticoagulant that modulates venous thrombosis. It shows that ESM1 deficiency triggers vascular occlusion in zebrafish and mice, whereas its restoration or overexpression prolongs clot‐formation time. Mechanistic analyses reveal that ESM1 activates HCII through its dermatan‐sulfate chain, uncovering a ...
Changsheng Chen   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy